| Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
| NPT1788 |
Individual protein |
Alpha-1a adrenergic receptor |
Homo sapiens |
AC50 |
= |
12000.0 |
nM |
PMID[37468498] |
| NPT230 |
Individual protein |
Bradykinin B2 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT232 |
Individual protein |
Cannabinoid CB1 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT234 |
Individual protein |
C-C chemokine receptor type 2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT236 |
Individual protein |
C-C chemokine receptor type 5 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT213 |
Individual protein |
Cytochrome P450 2C19 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT213 |
Individual protein |
Cytochrome P450 2C19 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT241 |
Individual protein |
Cytochrome P450 2E1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT249 |
Individual protein |
Glucocorticoid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT260 |
Individual protein |
Melanocortin receptor 5 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT262 |
Individual protein |
Muscarinic acetylcholine receptor M1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT110 |
Individual protein |
Cytochrome P450 2D6 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT252 |
Individual protein |
Histamine H2 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT229 |
Individual protein |
Angiotensin II type 2 (AT-2) receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT31 |
Individual protein |
Cyclooxygenase-2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT108 |
Individual protein |
Estrogen receptor alpha |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT263 |
Individual protein |
Muscarinic acetylcholine receptor M2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT265 |
Individual protein |
Muscarinic acetylcholine receptor M4 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT264 |
Individual protein |
Muscarinic acetylcholine receptor M3 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT31 |
Individual protein |
Cyclooxygenase-2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT253 |
Individual protein |
HMG-CoA reductase |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT278 |
Individual protein |
Cathepsin G |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT289 |
Individual protein |
Serotonin 1b (5-HT1b) receptor |
Rattus norvegicus |
Ki |
= |
9.263 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT145 |
Individual protein |
Mu opioid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT295 |
Individual protein |
Serotonin transporter |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT216 |
Individual protein |
Adenosine A1 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT270 |
Individual protein |
Nitric oxide synthase, inducible |
Mus musculus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT282 |
Individual protein |
MAP kinase ERK2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT282 |
Individual protein |
MAP kinase ERK2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
Ki |
= |
0.8 |
nM |
PMID[20958049] |
| NPT286 |
Individual protein |
Receptor protein-tyrosine kinase erbB-2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT275 |
Individual protein |
Progesterone receptor |
Bos taurus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT299 |
Individual protein |
Androgen Receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT249 |
Individual protein |
Glucocorticoid receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
AC50 |
= |
3.1 |
nM |
PMID[37468498] |
| NPT283 |
Individual protein |
MAP kinase p38 alpha |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT284 |
Individual protein |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT204 |
Individual protein |
Acetylcholinesterase |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT271 |
Individual protein |
Delta opioid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT225 |
Individual protein |
Beta-1 adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT1623 |
Individual protein |
DNA polymerase III |
Bacillus subtilis (strain 168) |
Potency |
n.a. |
26679.5 |
nM |
PubChem BioAssay data set |
| NPT298 |
Individual protein |
Neurokinin 2 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT272 |
Individual protein |
Kappa opioid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT283 |
Individual protein |
MAP kinase p38 alpha |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT288 |
Individual protein |
Serotonin 1a (5-HT1a) receptor |
Rattus norvegicus |
Ki |
= |
2.326 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT292 |
Individual protein |
Serotonin 2c (5-HT2c) receptor |
Homo sapiens |
IC50 |
= |
13.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT294 |
Individual protein |
Serotonin 6 (5-HT6) receptor |
Homo sapiens |
IC50 |
= |
2.538 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT279 |
Individual protein |
Leukocyte elastase |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT277 |
Individual protein |
Caspase-1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT284 |
Individual protein |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT13 |
Individual protein |
Tyrosine-protein kinase LCK |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT280 |
Individual protein |
Matrix metalloproteinase 9 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT110 |
Individual protein |
Cytochrome P450 2D6 |
Homo sapiens |
IC50 |
= |
200.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT1788 |
Individual protein |
Alpha-1a adrenergic receptor |
Homo sapiens |
AC50 |
= |
20.0 |
nM |
PMID[37468498] |
| NPT303 |
Individual protein |
Vasopressin V1a receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
Ki |
= |
539.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT243 |
Individual protein |
Dopamine D2 receptor |
Homo sapiens |
IC50 |
= |
829.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT244 |
Individual protein |
Dopamine D3 receptor |
Homo sapiens |
IC50 |
= |
167.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT245 |
Individual protein |
Dopamine D4 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT247 |
Individual protein |
Endothelin receptor ET-A |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT248 |
Individual protein |
Estrogen receptor beta |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT251 |
Individual protein |
Histamine H1 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT259 |
Individual protein |
Melanocortin receptor 4 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT31 |
Individual protein |
Cyclooxygenase-2 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT1410 |
Individual protein |
GABA receptor alpha-1 subunit |
Rattus norvegicus |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT272 |
Individual protein |
Kappa opioid receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT232 |
Individual protein |
Cannabinoid CB1 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT224 |
Individual protein |
Alpha-2c adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT263 |
Individual protein |
Muscarinic acetylcholine receptor M2 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT300 |
Individual protein |
Thromboxane-A synthase |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT219 |
Individual protein |
Alpha-1a adrenergic receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT237 |
Individual protein |
Interleukin-8 receptor A |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT239 |
Individual protein |
Cholecystokinin A receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT212 |
Individual protein |
Cytochrome P450 2C9 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT253 |
Individual protein |
HMG-CoA reductase |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT255 |
Individual protein |
Leukotriene C4 synthase |
Cavia porcellus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT257 |
Individual protein |
Arachidonate 15-lipoxygenase |
Oryctolagus cuniculus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT264 |
Individual protein |
Muscarinic acetylcholine receptor M3 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT252 |
Individual protein |
Histamine H2 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
Ki |
= |
0.958 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT218 |
Individual protein |
Adenosine A3 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT249 |
Individual protein |
Glucocorticoid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT217 |
Individual protein |
Adenosine A2a receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT279 |
Individual protein |
Leukocyte elastase |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT276 |
Individual protein |
Angiotensin-converting enzyme |
Oryctolagus cuniculus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT224 |
Individual protein |
Alpha-2c adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT267 |
Individual protein |
Neuropeptide Y receptor type 1 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT274 |
Individual protein |
Platelet activating factor receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT281 |
Individual protein |
MAP kinase ERK1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT216 |
Individual protein |
Adenosine A1 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT222 |
Individual protein |
Alpha-2a adrenergic receptor |
Homo sapiens |
Ki |
= |
596.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT223 |
Individual protein |
Alpha-2b adrenergic receptor |
Homo sapiens |
IC50 |
= |
461.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT223 |
Individual protein |
Alpha-2b adrenergic receptor |
Homo sapiens |
Ki |
= |
210.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
Potency |
n.a. |
326.4 |
nM |
PubChem BioAssay data set |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
Potency |
n.a. |
446.7 |
nM |
PubChem BioAssay data set |
| NPT264 |
Individual protein |
Muscarinic acetylcholine receptor M3 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT293 |
Individual protein |
Serotonin 4 (5-HT4) receptor |
Cavia porcellus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT274 |
Individual protein |
Platelet activating factor receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT301 |
Individual protein |
Vascular endothelial growth factor receptor 1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT303 |
Individual protein |
Vasopressin V1a receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT236 |
Individual protein |
C-C chemokine receptor type 5 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT247 |
Individual protein |
Endothelin receptor ET-A |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT257 |
Individual protein |
Arachidonate 15-lipoxygenase |
Oryctolagus cuniculus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT13 |
Individual protein |
Tyrosine-protein kinase LCK |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT287 |
Individual protein |
Leukocyte common antigen |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT290 |
Individual protein |
Serotonin 2a (5-HT2a) receptor |
Homo sapiens |
Ki |
= |
0.728 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT108 |
Individual protein |
Estrogen receptor alpha |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
EC50 |
= |
21.38 |
nM |
PMID[20958049] |
| NPT212 |
Individual protein |
Cytochrome P450 2C9 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT198 |
Individual protein |
Vitamin D receptor |
Homo sapiens |
Potency |
n.a. |
14125.4 |
nM |
PubChem BioAssay data set |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
IC50 |
= |
1.505 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT225 |
Individual protein |
Beta-1 adrenergic receptor |
Homo sapiens |
AC50 |
= |
3600.0 |
nM |
PMID[37468498] |
| NPT290 |
Individual protein |
Serotonin 2a (5-HT2a) receptor |
Homo sapiens |
AC50 |
= |
7.2 |
nM |
PMID[37468498] |
| NPT233 |
Individual protein |
Carbonic anhydrase II |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT259 |
Individual protein |
Melanocortin receptor 4 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT261 |
Individual protein |
Monoamine oxidase A |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT261 |
Individual protein |
Monoamine oxidase A |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT229 |
Individual protein |
Angiotensin II type 2 (AT-2) receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT243 |
Individual protein |
Dopamine D2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT239 |
Individual protein |
Cholecystokinin A receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT288 |
Individual protein |
Serotonin 1a (5-HT1a) receptor |
Rattus norvegicus |
IC50 |
= |
4.07 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT278 |
Individual protein |
Cathepsin G |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT208 |
Individual protein |
Cytochrome P450 1A2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT226 |
Individual protein |
Beta-2 adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT104 |
Individual protein |
Cerebroside-sulfatase |
Homo sapiens |
Potency |
n.a. |
23934.1 |
nM |
PubChem BioAssay data set |
| NPT217 |
Individual protein |
Adenosine A2a receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT204 |
Individual protein |
Acetylcholinesterase |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT220 |
Individual protein |
Alpha-1b adrenergic receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT100 |
Individual protein |
Glutaminase kidney isoform, mitochondrial |
Homo sapiens |
Potency |
n.a. |
11220.2 |
nM |
PubChem BioAssay data set |
| NPT2769 |
Individual protein |
Thromboxane A2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT224 |
Individual protein |
Alpha-2c adrenergic receptor |
Homo sapiens |
AC50 |
= |
1700.0 |
nM |
PMID[37468498] |
| NPT219 |
Individual protein |
Alpha-1a adrenergic receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT221 |
Individual protein |
Alpha-1d adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT225 |
Individual protein |
Beta-1 adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT252 |
Individual protein |
Histamine H2 receptor |
Homo sapiens |
AC50 |
= |
58.0 |
nM |
PMID[37468498] |
| NPT222 |
Individual protein |
Alpha-2a adrenergic receptor |
Homo sapiens |
AC50 |
= |
17000.0 |
nM |
PMID[37468498] |
| NPT228 |
Individual protein |
Norepinephrine transporter |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
AC50 |
= |
25.7 |
nM |
PMID[37468498] |
| NPT216 |
Individual protein |
Adenosine A1 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT299 |
Individual protein |
Androgen Receptor |
Rattus norvegicus |
AC50 |
= |
17999.9 |
nM |
PMID[37468498] |
| NPT251 |
Individual protein |
Histamine H1 receptor |
Homo sapiens |
AC50 |
= |
2600.0 |
nM |
PMID[37468498] |
| NPT1163 |
Individual protein |
Glutamate (NMDA) receptor subunit zeta 1 |
Rattus norvegicus |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT247 |
Individual protein |
Endothelin receptor ET-A |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT223 |
Individual protein |
Alpha-2b adrenergic receptor |
Homo sapiens |
AC50 |
= |
350.0 |
nM |
PMID[37468498] |
| NPT145 |
Individual protein |
Mu opioid receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT261 |
Individual protein |
Monoamine oxidase A |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
AC50 |
= |
5.4 |
nM |
PMID[37468498] |
| NPT230 |
Individual protein |
Bradykinin B2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT1647 |
Individual protein |
Vasopressin V2 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT271 |
Individual protein |
Delta opioid receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT291 |
Individual protein |
Serotonin 2b (5-HT2b) receptor |
Homo sapiens |
AC50 |
= |
3.7 |
nM |
PMID[37468498] |
| NPT292 |
Individual protein |
Serotonin 2c (5-HT2c) receptor |
Homo sapiens |
AC50 |
= |
120.0 |
nM |
PMID[37468498] |
| NPT1464 |
Individual protein |
Phosphodiesterase 4D |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT218 |
Individual protein |
Adenosine A3 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT262 |
Individual protein |
Muscarinic acetylcholine receptor M1 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT246 |
Individual protein |
Dopamine transporter |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT246 |
Individual protein |
Dopamine transporter |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT240 |
Individual protein |
Cytochrome P450 2A6 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT269 |
Individual protein |
Nitric-oxide synthase, brain |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT182 |
Individual protein |
Protein kinase C alpha |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT297 |
Individual protein |
Neurokinin 1 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT135 |
Individual protein |
Chromobox protein homolog 1 |
Homo sapiens |
Potency |
n.a. |
79432.8 |
nM |
PubChem BioAssay data set |
| NPT273 |
Individual protein |
Phosphodiesterase 5A |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT289 |
Individual protein |
Serotonin 1b (5-HT1b) receptor |
Rattus norvegicus |
IC50 |
= |
15.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT272 |
Individual protein |
Kappa opioid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT276 |
Individual protein |
Angiotensin-converting enzyme |
Oryctolagus cuniculus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT285 |
Individual protein |
Epidermal growth factor receptor erbB1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT292 |
Individual protein |
Serotonin 2c (5-HT2c) receptor |
Homo sapiens |
Ki |
= |
6.558 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT298 |
Individual protein |
Neurokinin 2 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT301 |
Individual protein |
Vascular endothelial growth factor receptor 1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT217 |
Individual protein |
Adenosine A2a receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT220 |
Individual protein |
Alpha-1b adrenergic receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT222 |
Individual protein |
Alpha-2a adrenergic receptor |
Homo sapiens |
IC50 |
= |
1590.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT277 |
Individual protein |
Caspase-1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT296 |
Individual protein |
Sigma opioid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT218 |
Individual protein |
Adenosine A3 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT221 |
Individual protein |
Alpha-1d adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT227 |
Individual protein |
Beta-3 adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT230 |
Individual protein |
Bradykinin B2 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT235 |
Individual protein |
C-C chemokine receptor type 4 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT239 |
Individual protein |
Cholecystokinin A receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT246 |
Individual protein |
Dopamine transporter |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT108 |
Individual protein |
Estrogen receptor alpha |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT256 |
Individual protein |
Cysteinyl leukotriene receptor 1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT256 |
Individual protein |
Cysteinyl leukotriene receptor 1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT262 |
Individual protein |
Muscarinic acetylcholine receptor M1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT267 |
Individual protein |
Neuropeptide Y receptor type 1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT275 |
Individual protein |
Progesterone receptor |
Bos taurus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT280 |
Individual protein |
Matrix metalloproteinase 9 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT14 |
Individual protein |
Tyrosine-protein kinase FYN |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT287 |
Individual protein |
Leukocyte common antigen |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT145 |
Individual protein |
Mu opioid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT285 |
Individual protein |
Epidermal growth factor receptor erbB1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT303 |
Individual protein |
Vasopressin V1a receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT296 |
Individual protein |
Sigma opioid receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT297 |
Individual protein |
Neurokinin 1 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT227 |
Individual protein |
Beta-3 adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT233 |
Individual protein |
Carbonic anhydrase II |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT235 |
Individual protein |
C-C chemokine receptor type 4 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT30 |
Individual protein |
Cyclooxygenase-1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT241 |
Individual protein |
Cytochrome P450 2E1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
IC50 |
= |
1077.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT245 |
Individual protein |
Dopamine D4 receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT251 |
Individual protein |
Histamine H1 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT255 |
Individual protein |
Leukotriene C4 synthase |
Cavia porcellus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT263 |
Individual protein |
Muscarinic acetylcholine receptor M2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT265 |
Individual protein |
Muscarinic acetylcholine receptor M4 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT242 |
Individual protein |
Dopamine D1 receptor |
Homo sapiens |
Potency |
n.a. |
5.2 |
nM |
PubChem BioAssay data set |
| NPT295 |
Individual protein |
Serotonin transporter |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT228 |
Individual protein |
Norepinephrine transporter |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT244 |
Individual protein |
Dopamine D3 receptor |
Homo sapiens |
AC50 |
= |
290.0 |
nM |
PMID[37468498] |
| NPT222 |
Individual protein |
Alpha-2a adrenergic receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT109 |
Individual protein |
Cytochrome P450 3A4 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT281 |
Individual protein |
MAP kinase ERK1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT14 |
Individual protein |
Tyrosine-protein kinase FYN |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT286 |
Individual protein |
Receptor protein-tyrosine kinase erbB-2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT293 |
Individual protein |
Serotonin 4 (5-HT4) receptor |
Cavia porcellus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT294 |
Individual protein |
Serotonin 6 (5-HT6) receptor |
Homo sapiens |
Ki |
= |
1.178 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT260 |
Individual protein |
Melanocortin receptor 5 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT266 |
Individual protein |
Muscarinic acetylcholine receptor M5 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT266 |
Individual protein |
Muscarinic acetylcholine receptor M5 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT267 |
Individual protein |
Neuropeptide Y receptor type 1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT1005 |
Individual protein |
Tumor susceptibility gene 101 protein |
Homo sapiens |
Potency |
n.a. |
44668.4 |
nM |
PubChem BioAssay data set |
| NPT269 |
Individual protein |
Nitric-oxide synthase, brain |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT270 |
Individual protein |
Nitric oxide synthase, inducible |
Mus musculus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT271 |
Individual protein |
Delta opioid receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT290 |
Individual protein |
Serotonin 2a (5-HT2a) receptor |
Homo sapiens |
IC50 |
= |
2.547 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT295 |
Individual protein |
Serotonin transporter |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT244 |
Individual protein |
Dopamine D3 receptor |
Homo sapiens |
Ki |
= |
57.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT273 |
Individual protein |
Phosphodiesterase 5A |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT299 |
Individual protein |
Androgen Receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT300 |
Individual protein |
Thromboxane-A synthase |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT226 |
Individual protein |
Beta-2 adrenergic receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT226 |
Individual protein |
Beta-2 adrenergic receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT228 |
Individual protein |
Norepinephrine transporter |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT232 |
Individual protein |
Cannabinoid CB1 receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT234 |
Individual protein |
C-C chemokine receptor type 2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT237 |
Individual protein |
Interleukin-8 receptor A |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT208 |
Individual protein |
Cytochrome P450 1A2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT240 |
Individual protein |
Cytochrome P450 2A6 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT109 |
Individual protein |
Cytochrome P450 3A4 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT182 |
Individual protein |
Protein kinase C alpha |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT248 |
Individual protein |
Estrogen receptor beta |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT30 |
Individual protein |
Cyclooxygenase-1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT243 |
Individual protein |
Dopamine D2 receptor |
Homo sapiens |
Ki |
= |
276.0 |
nM |
DrugMatrix in vitro pharmacology data |
| NPT803 |
Individual protein |
Flap endonuclease 1 |
Homo sapiens |
Potency |
n.a. |
13371.4 |
nM |
PubChem BioAssay data set |
| NPT50 |
Individual protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
n.a. |
29855.4 |
nM |
PubChem BioAssay data set |
| NPT483 |
Individual protein |
Prelamin-A/C |
Homo sapiens |
Potency |
= |
12589.3 |
nM |
PubChem BioAssay data set |
| NPT987 |
Individual protein |
Histamine H3 receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT713 |
Individual protein |
Bile salt export pump |
Homo sapiens |
AC50 |
> |
300000.0 |
nM |
PMID[37468498] |
| NPT5301 |
Individual protein |
Motilin receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT7 |
Individual protein |
Thioredoxin reductase 1, cytoplasmic |
Rattus norvegicus |
Potency |
n.a. |
16833.6 |
nM |
PubChem BioAssay data set |
| NPT29430 |
Single protein |
Neuronal acetylcholine receptor protein alpha-4 subunit |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT7 |
Individual protein |
Thioredoxin reductase 1, cytoplasmic |
Rattus norvegicus |
Potency |
n.a. |
2667.9 |
nM |
PubChem BioAssay data set |
| NPT444 |
Individual protein |
Ubiquitin carboxyl-terminal hydrolase 1 |
Homo sapiens |
Potency |
n.a. |
56234.1 |
nM |
PubChem BioAssay data set |
| NPT69 |
Individual protein |
Matrix metalloproteinase-1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT94 |
Individual protein |
Aldehyde dehydrogenase 1A1 |
Homo sapiens |
Potency |
= |
3548.1 |
nM |
PubChem BioAssay data set |
| NPT4358 |
Individual protein |
Type-1 angiotensin II receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT698 |
Individual protein |
Regulator of G-protein signaling 4 |
Homo sapiens |
Potency |
n.a. |
15003.0 |
nM |
PubChem BioAssay data set |
| NPT7 |
Individual protein |
Thioredoxin reductase 1, cytoplasmic |
Rattus norvegicus |
Potency |
n.a. |
35481.3 |
nM |
PubChem BioAssay data set |
| NPT800 |
Individual protein |
M-phase phosphoprotein 8 |
Homo sapiens |
Potency |
n.a. |
26679.5 |
nM |
PubChem BioAssay data set |
| NPT692 |
Individual protein |
Histone deacetylase 6 |
Homo sapiens |
Inhibition |
= |
-28.68 |
% |
HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
| NPT98 |
Individual protein |
HERG |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT542 |
Individual protein |
Progesterone receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT4729 |
Individual protein |
Cholecystokinin B receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT98 |
Individual protein |
HERG |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT29498 |
Single protein |
Interleukin-8 receptor B |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT98 |
Individual protein |
HERG |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT68 |
Individual protein |
Aldose reductase |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT68 |
Individual protein |
Aldose reductase |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT69 |
Individual protein |
Matrix metalloproteinase-1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT29498 |
Single protein |
Interleukin-8 receptor B |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT692 |
Individual protein |
Histone deacetylase 6 |
Homo sapiens |
Inhibition |
= |
-4.42 |
% |
HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
| NPT67 |
Individual protein |
Cholinesterase |
Equus caballus |
Inhibition |
= |
-12.73 |
% |
PMID[23062825] |
| NPT20859 |
Single protein |
Neuropeptide Y receptor type 2 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT755 |
Individual protein |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Homo sapiens |
Potency |
n.a. |
23934.1 |
nM |
PubChem BioAssay data set |
| NPT66 |
Individual protein |
Acetylcholinesterase |
Electrophorus electricus |
Inhibition |
= |
6.45 |
% |
PMID[23062825] |
| NPT5104 |
Individual protein |
Phosphodiesterase 3A |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT93 |
Individual protein |
Survival motor neuron protein |
Homo sapiens |
Potency |
= |
12589.3 |
nM |
PubChem BioAssay data set |
| NPT28814 |
Single protein |
Ghrelin receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT445 |
Individual protein |
Peripheral myelin protein 22 |
Rattus norvegicus |
Potency |
n.a. |
18105.6 |
nM |
PubChem BioAssay data set |
| NPT92 |
Individual protein |
Serotonin 1a (5-HT1a) receptor |
Homo sapiens |
AC50 |
= |
14.4 |
nM |
PMID[37468498] |
| NPT29454 |
Single protein |
Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 |
Homo sapiens |
Inhibition |
= |
-14.52 |
% |
PMID[38318365] |
| NPT20859 |
Single protein |
Neuropeptide Y receptor type 2 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT51 |
Individual protein |
Microtubule-associated protein tau |
Homo sapiens |
Potency |
= |
5011.9 |
nM |
PubChem BioAssay data set |
| NPT5975 |
Individual protein |
Cyclooxygenase-1 |
Rattus norvegicus |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT30010 |
Single protein |
Calcitonin receptor |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT29442 |
Protein complex group |
Glycine receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT47 |
Individual protein |
ATP-dependent DNA helicase Q1 |
Homo sapiens |
Potency |
= |
35481.3 |
nM |
PubChem BioAssay data set |
| NPT425 |
Individual protein |
Serotonin 3a (5-HT3a) receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT45 |
Individual protein |
Ubiquitin carboxyl-terminal hydrolase 2 |
Homo sapiens |
Potency |
= |
14689.2 |
nM |
PubChem BioAssay data set |
| NPT53 |
Individual protein |
4'-phosphopantetheinyl transferase ffp |
Bacillus subtilis |
Potency |
= |
44668.4 |
nM |
PubChem BioAssay data set |
| NPT62 |
Individual protein |
6-phospho-1-fructokinase |
Trypanosoma brucei |
Potency |
n.a. |
19011.5 |
nM |
PubChem BioAssay data set |
| NPT4037 |
Individual protein |
Multidrug and toxin extrusion protein 1 |
Homo sapiens |
Inhibition |
= |
12.0 |
% |
PMID[23241029] |
| NPT28550 |
Single protein |
Vasoactive intestinal polypeptide receptor 1 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT543 |
Individual protein |
Pregnane X receptor |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT49 |
Individual protein |
DNA-(apurinic or apyrimidinic site) lyase |
Homo sapiens |
Potency |
n.a. |
35481.3 |
nM |
PubChem BioAssay data set |
| NPT30151 |
Single protein |
Melanocortin receptor 3 |
Homo sapiens |
AC50 |
> |
30000.0 |
nM |
PMID[37468498] |
| NPT4037 |
Individual protein |
Multidrug and toxin extrusion protein 1 |
Homo sapiens |
IC50 |
> |
250000.0 |
nM |
PMID[23241029] |
| NPT28550 |
Single protein |
Vasoactive intestinal polypeptide receptor 1 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT29442 |
Protein complex group |
Glycine receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT28398 |
Single protein |
Insulin receptor |
Rattus norvegicus |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT5 |
Individual protein |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Homo sapiens |
Potency |
n.a. |
14125.4 |
nM |
PubChem BioAssay data set |
| NPT28398 |
Single protein |
Insulin receptor |
Rattus norvegicus |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT30151 |
Single protein |
Melanocortin receptor 3 |
Homo sapiens |
Ki |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT30010 |
Single protein |
Calcitonin receptor |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |
| NPT30151 |
Single protein |
Melanocortin receptor 3 |
Homo sapiens |
IC50 |
n.a. |
n.a. |
n.a. |
DrugMatrix in vitro pharmacology data |